“COMPARATIVE ANALYSIS OF QUESTIONNAIRE DATA TO ASSESS GROWTH HORMONE DEFICIENCY IN ADULTS QOL AGHD IN PATIENTS WITH INCIDENTALOMAS AND INACTIVE PITUITARY ADENOMAS”

Authors

  • Urmanova Yu.M Tashkent Pediatric Medical Institute, Department of Endocrinology with Pediatric Endocrinology, Department of Surgical Diseases
  • Khudaibergenov Sh.A Tashkent Pediatric Medical Institute, Department of Endocrinology with Pediatric Endocrinology, Department of Surgical Diseases
  • Kholikov F.Zh Tashkent Pediatric Medical Institute, Department of Endocrinology with Pediatric Endocrinology, Department of Surgical Diseases The Republic of Uzbekistan

Keywords:

QoL AGHD, incidentalomas and inactive, pituitary adenomas

Abstract

perform a comparative analysis of data from a questionnaire to assess growth hormone deficiency in adults QoL AGHD in patients with incidentalomas and inactive pituitary adenomas

References

Savastano S,Di Somma C,Belfiore A,Guida B/Growth hormone status in morbidly obese subjects and correlation with body composition.//J Endocrinol Invest.2006Jun;29(6):536-43.

Sara M,Claudio F,Marco L et all.Michelle RTimecourse of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors. //Radiother Oncol.2011 Apr;99(1):23-8. Epub 2011 Mar 30.

Sauer N, et al. Non-functioning pituitary macroadenomas: Benefit from early growth hormone substitution after surgery. Growth Horm IGF Res. 2014 Apr-Jun.

Sanmarti A, Lucas A, Hawkins F, et all. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study): Socio-economic impact and health status.// Eur Jendocrinol 1999;141:481^189.Sibal I et al. /Pituitary apoplexy; a review of clinical presentation, management and outcomes.// Pituitary. 2005; 157-163

Schwarz H.P. Growth hormone: who can benefit from it? // Ther Umsch. 1995 Oct;52(10):678-81.

Shen L.Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis. //Neurol Sci. 2015. PMID26048536 [PubMed – indexed for MEDLINE]

Svensson J, Bengtsson B-Å, Rosen T, Oden A & Johannsson G. /Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. //Journal of Clinical Endocrinology and Metabolism 2004 89 3306–3312. [Abstract/Free Full Text])

Tanriverdi F, et al. Classical and non-classical causes of GH deficiency in adults.Review article //Best Pract Res Clin Endocrinol Metab. 2017. PMID 28477730//Clinical Endocrinology & Metabolism 31 (2017) 49-57

Tirosh A, et al. IGF-I levels reflect hypopituitarism severity in adults with pituitary dysfunction//.Pituitary. 2016.Aug;19(4):399-406. doi:10.1007/s11102-016-0718-1.

Wüster C, Melchinger U, Eversmann T, Hensen J. Reduced incidence of side-effects of growth hormone substitution in 404 patients with hypophyseal insufficiency. Results of a multicenter indications study // Med Klin (Munich Et 1998 Oct 15;93(10):585-91.

Downloads

Published

2024-05-06

How to Cite

Urmanova Yu.M, Khudaibergenov Sh.A, & Kholikov F.Zh. (2024). “COMPARATIVE ANALYSIS OF QUESTIONNAIRE DATA TO ASSESS GROWTH HORMONE DEFICIENCY IN ADULTS QOL AGHD IN PATIENTS WITH INCIDENTALOMAS AND INACTIVE PITUITARY ADENOMAS”. European Journal of Agricultural and Rural Education, 5(5), 1-4. Retrieved from https://scholarzest.com/index.php/ejare/article/view/4533

Issue

Vol. 5 No. 5 (2024): EJARE

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.